Variable | Univariate | Multivariate | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age at diagnosis | 1.022 (0.986–1.059) | 0.235 |  |  |
Gender | 1.725 (0.728–4.086) | 0.215 |  |  |
Smoking status | 1.205 (0.614–2.366) | 0.588 |  |  |
T stage (1–2 vs 3–4) | 2.247 (1.215–4.157) | 0.010* | 2.610 (1.364–4.993) | 0.004* |
N stage (0–2 vs 3) | 1.513 (0.771–2.968) | 0.229 | 2.160 (1.056–4.417) | 0.035* |
CRT-D (months) | 1.219 (1.024–1.451) | 0.026* | 1.227 (1.026–1.466) | 0.025* |
Variable | HR (95% CI) | P | HR (95% CI) | P |
Age at diagnosis | 1.022 (0.986–1.059) | 0.235 |  |  |
Gender | 1.725 (0.728–4.086) | 0.215 |  |  |
Smoking status | 1.205 (0.614–2.366) | 0.588 |  |  |
T stage (1–2 vs 3–4) | 2.247 (1.215–4.157) | 0.010* | 2.637 (1.348–5.158) | 0.005* |
N stage (0–2 vs 3) | 1.513 (0.771–2.968) | 0.229 | 2.016 (0.967–4.202) | 0.061 |
pre-PCI BM | 4.336 (2.421–7.765) | <  0.001* | 4.143 (2.318–7.406) | <  0.001* |